BIO-MD

Serial Number 85336863
606

Registration Progress

Application Filed
Jun 2, 2011
Under Examination
Aug 7, 2012
Approved for Publication
Jun 12, 2012
Published for Opposition
Jun 12, 2012
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BIO-MD
Previous Owner: SIGNATURE THERAPEUTICS, INC.
Classes: 005

Trademark Image

BIO-MD

Basic Information

Serial Number
85336863
Filing Date
June 2, 2011
Published for Opposition
June 12, 2012
Abandonment Date
September 7, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 7, 2015
Classes
005

Rights Holder

SIGNATURE THERAPEUTICS, INC.

03
Address
1731 Embarcadero Road, Suite 220
Palo Alto, CA 94303

Ownership History

PharmacoFore, Inc.

Original Applicant
03
San Carlos, CA

SIGNATURE THERAPEUTICS, INC.

New Owner Before Publication #1
03
SAN CARLOS, CA

SIGNATURE THERAPEUTICS, INC.

Owner at Publication
03
Palo Alto, CA

Legal Representation

Attorney
R. Gwen Peterson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

42 events
Date Code Type Description Documents
Sep 8, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Sep 7, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 27, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 26, 2015 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 21, 2015 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 21, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 31, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 30, 2014 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 28, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 28, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 28, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 28, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 18, 2013 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 16, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 16, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 16, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 5, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 22, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 4, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 22, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 7, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 12, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 12, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 23, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 9, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 8, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 12, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 6, 2012 ALIE A ASSIGNED TO LIE Loading...
Mar 28, 2012 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 26, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 27, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 27, 2011 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 27, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 17, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 8, 2011 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Jun 7, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 6, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, drug precursors, administered in a variety of forms and through various routes, that function as drug delivery agents to provide controlled release of active ingredients for a wide variety of pharmaceuticals, resulting in benefits such as a modified PK profile, tamper resistance, abuse resistance and overdose protection
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
BIO MEDICAL

Classification

International Classes
005